These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 15940415

  • 1. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M, Qurishi N, Hoffmann C, Hochdorfer B, Brockmeyer NH, Arasteh K, Mauss S, Rockstroh JK, German Clinical AIDS Working Group (KAAD).
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [Abstract] [Full Text] [Related]

  • 2. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F, Mosam A, Henry LN, Chisholm JV, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C.
    AIDS; 2007 Jun 19; 21(10):1245-52. PubMed ID: 17545700
    [Abstract] [Full Text] [Related]

  • 3. Resolution of severe Kaposi's sarcoma after initiation of antiretroviral triple therapy.
    Jung C, Bogner JR, Goebel F.
    Eur J Med Res; 1998 Sep 17; 3(9):439-42. PubMed ID: 9737891
    [Abstract] [Full Text] [Related]

  • 4. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L, Palacios R, Valencia E, Saballs P, Sirera G, Santos I, Baldobí F, Alegre M, Goyenechea A, Pedreira J, González del Castillo J, Martínez-Lacasa J, Ocampo A, Alsina M, Santos J, Podzamczer D, González-Lahoz J, Caelyx/Kaposi's Sarcoma Spanish Group.
    Clin Infect Dis; 2008 Aug 01; 47(3):410-7. PubMed ID: 18582203
    [Abstract] [Full Text] [Related]

  • 5. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC, Spittle MF, Mitchell S, Kulasegaram R.
    Int J STD AIDS; 2006 Aug 01; 17(8):565-6. PubMed ID: 16925908
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W.
    Oncologist; 2007 Jan 01; 12(1):114-23. PubMed ID: 17227906
    [Abstract] [Full Text] [Related]

  • 7. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM, Calabrò ML, De Rossi A, Aversa SM, Barbierato M, Trevenzoli M, Gasperini P, Zanchetta M, Cadrobbi P, Monfardini S, Chieco-Bianchi L.
    Int J Oncol; 2005 Sep 01; 27(3):779-85. PubMed ID: 16077928
    [Abstract] [Full Text] [Related]

  • 8. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.
    HIV Med; 2006 Mar 01; 7(2):99-104. PubMed ID: 16420254
    [Abstract] [Full Text] [Related]

  • 9. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF, Okwundu CI, Dedicoat M, Freeman EE.
    Cochrane Database Syst Rev; 2014 Aug 13; 8(8):CD003256. PubMed ID: 25221796
    [Abstract] [Full Text] [Related]

  • 10. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF, Okwundu CI, Dedicoat M, Freeman EE.
    Cochrane Database Syst Rev; 2014 Aug 13; (9):CD003256. PubMed ID: 25313415
    [Abstract] [Full Text] [Related]

  • 11. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
    Lasso M, Pérez J, Noriega L, Malebrán A, Espinoza S.
    Rev Med Chil; 2003 May 13; 131(5):483-90. PubMed ID: 12879808
    [Abstract] [Full Text] [Related]

  • 12. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD, Keruly JC.
    Clin Infect Dis; 2007 Feb 01; 44(3):441-6. PubMed ID: 17205456
    [Abstract] [Full Text] [Related]

  • 13. Kaposi's sarcoma: DaunoXome approved.
    AIDS Treat News; 1996 May 03; (no 246):3-4. PubMed ID: 11363485
    [Abstract] [Full Text] [Related]

  • 14. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V, Caumes E, Gambotti L, Ittah H, Morini JP, Deleuze J, Gorin I, Katlama C, Bricaire F, Dupin N.
    Br J Cancer; 2006 Apr 10; 94(7):1000-6. PubMed ID: 16570046
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
    Rizzieri DA, Liu J, Miralles D, Traweek ST.
    Cancer J Sci Am; 1997 Apr 10; 3(3):153-6. PubMed ID: 9161780
    [Abstract] [Full Text] [Related]

  • 17. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
    Hermans P, Clumeck N, Picard O, van Vooren JP, Duriez P, Zucman D, Bryant JL, Gill P, Lunardi-Iskandar Y, Gallo RC.
    J Hum Virol; 1998 Apr 10; 1(2):82-9. PubMed ID: 10195236
    [Abstract] [Full Text] [Related]

  • 18. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
    Martin-Carbonero L, Barrios A, Saballs P, Sirera G, Santos J, Palacios R, Valencia ME, Alegre M, Podzamczer D, González-Lahoz J, Caelyx/KS Spanish Group.
    AIDS; 2004 Aug 20; 18(12):1737-40. PubMed ID: 15280789
    [Abstract] [Full Text] [Related]

  • 19. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW, Remick SC, Azarnia N, Proper JA, Barrueco JR, Dezube BJ.
    Clin Cancer Res; 1999 Nov 20; 5(11):3432-7. PubMed ID: 10589755
    [Abstract] [Full Text] [Related]

  • 20. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
    Prescrire Int; 1998 Jun 20; 7(35):69-70. PubMed ID: 10342919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.